Orforglipron
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity
Eli Lilly · Phase 3 · Active, not recruiting · Enrollment 800
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.